Biomarker Analysis for Preclinical and Clinical Studies

Quantitative methods for translational markers in preclinical and clinical discovery.

SPEAK WITH A SCIENTIST

mdbiosciences-neurology-leading-preclinical-CRO-1

Biomarkers that add value early in drug development

 

The use of biomarkers has the potential to increase value early in drug development by extracting more data and information from each study. This can increase efficiency, reduce costs, guide decisions, boost the translational power of preclinical studies, and effectively enable more drug candidates to move forward. MD Biosciences has expertise with biomarker analysis for markers that play a role in neuroinflammation, neurodegeneration, and pain. The methods are listed below. 

 
REQUEST A STUDY QUOTE

Preclinical and Clinical Biomarker Assays

Click here for more information on histology services. 

Explore Our Resources

Translational biomarkers

Whitepaper: Translational Biomarkers

This whitepaper provides an overview of how biomarkers can be utilized to extract maximum value early in translational studies while being optimized for use in clinical studies.

> Download

whitepaper icon-inflammatory biomarker

Whitepaper: Inflammatory Biomarkers

The interplay between the central and peripheral nervous systems and the immune response highlights the importance of understanding the cellular and inflammatory attributes that are strongly associated with neurological diseases and pain.

> Download

Biomarkers

Whitepaper: Biomarker Detection

Multiplex and ultra-sensitive detection assays provide a powerful platform for difficult to measure analytes. The detection of these markers offers invaluable insight on monitoring disease progression at earlier stages and assessing the need for therapeutic intervention.

> Download

Add biomarkers to a study

Request a quote for biomarker panels on any model, or speak with a scientist about which markers fit the mechanism.

REQUEST A STUDY QUOTE
SPEAK WITH A SCIENTIST